ANVISA Defines Priority Foreign Regulatory Authorities
QR Group analyzes how the strategy strengthens regulatory trust and facilitates the registration of health products in Brazil In 2024, ANVISA released the list of priority foreign regulatory authorities to strengthen the process of regulatory trust in Brazil. The measure is part of the agency’s regulatory agenda and aims to streamline analysis and decisions through […]
ANVISA Receives Top Score for Good Regulatory Practices
QR Group analyzes the impact of agency performance for companies seeking registration of health products in Brazil ANVISA was rated 10 in the OECD Index of Good Regulatory Practices, according to a report released in April 2024. The index, prepared by the Organization for Economic Cooperation and Development, measures the quality of standard-making processes in […]
QR Group: How to Register Health Products with ANVISA and Ensure Compliance
Learn how QR Group can assist in the registration of health products with ANVISA and in the regulatory process to ensure entry into the Brazilian market. For a health product to be legally marketed in Brazil, it is essential that it goes through the registration process with ANVISA. This process involves a series of steps […]
